{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:41:56Z","timestamp":1790260916509,"version":"4.1.0"},"reference-count":108,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,19]]},"DOI":"10.1093\/ajhp\/zxy089","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T21:28:21Z","timestamp":1553030901000},"page":"424-435","source":"Crossref","is-referenced-by-count":121,"title":["The opioid crisis: Origins, trends, policies, and the roles of pharmacists"],"prefix":"10.1093","volume":"76","author":[{"given":"Marie A","family":"Chisholm-Burns","sequence":"first","affiliation":[{"name":"University of Tennessee Health Science Center College of Pharmacy, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A","family":"Spivey","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Sherwin","sequence":"additional","affiliation":[{"name":"University of Tennessee Health Science Center College of Pharmacy, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Knoxville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Hohmeier","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"2019061105193904500_CIT0001","author":"U.S. Department of Health and Human Services"},{"key":"2019061105193904500_CIT0002","author":"National Institute on Drug Abuse"},{"key":"2019061105193904500_CIT0003","author":"Centers for Disease Control and Prevention"},{"key":"2019061105193904500_CIT0004","author":"Tennessee Pharmacists Association"},{"key":"2019061105193904500_CIT0005","author":"California Pharmacists Association"},{"key":"2019061105193904500_CIT0006","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"key":"2019061105193904500_CIT0007","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bja.2017.11.098","article-title":"\u201cPain as the fifth vital sign\u201d and dependence on the \u201cnumerical pain scale\u201d is being abandoned in the US: why","volume":"120","author":"Levy","year":"2018","journal-title":"Br J Anaesth"},{"key":"2019061105193904500_CIT0008","first-page":"6","article-title":"The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society","volume":"13","author":"Haddox","year":"1997","journal-title":"Clin J Pain."},{"key":"2019061105193904500_CIT0009","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician."},{"key":"2019061105193904500_CIT0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10612-010-9113-9","article-title":"OxyContin and a regulation deficiency of the pharmaceutical industry: rethinking state-corporate crime","volume":"19","author":"Griffin","year":"2011","journal-title":"Critical Criminology."},{"key":"2019061105193904500_CIT0011","author":"Lopez"},{"key":"2019061105193904500_CIT0012","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMp1710756","article-title":"Drug companies\u2019 liability for the opioid epidemic","volume":"377","author":"Haffajee","year":"2017","journal-title":"N Engl J Med"},{"key":"2019061105193904500_CIT0013","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med"},{"key":"2019061105193904500_CIT0014","author":"Centers for Disease Control and Prevention"},{"key":"2019061105193904500_CIT0015","author":"Centers for Disease Control and Prevention"},{"key":"2019061105193904500_CIT0016","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"2019061105193904500_CIT0017","author":"Muhuri"},{"key":"2019061105193904500_CIT0018","article-title":"Short answers to hard questions about the opioid crisis (August 10, 2017)","author":"Katz"},{"key":"2019061105193904500_CIT0019","author":"National Institute on Drug Abuse"},{"key":"2019061105193904500_CIT0020","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/pds.1452","article-title":"Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States","volume":"16","author":"Cicero","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2019061105193904500_CIT0021","doi-asserted-by":"crossref","first-page":"e54496","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PLoS One."},{"key":"2019061105193904500_CIT0022","author":"Henry"},{"key":"2019061105193904500_CIT0023","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugpo.2017.06.003","article-title":"US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations","volume":"46","author":"Unick","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2019061105193904500_CIT0024","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.2015.11859","article-title":"Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003\u20132013","volume":"314","author":"Han","year":"2015","journal-title":"JAMA"},{"key":"2019061105193904500_CIT0025","article-title":"Opioid prescribing. Where you live matters","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"2019061105193904500_CIT0026","author":"Centers for Disease Control and Prevention"},{"key":"2019061105193904500_CIT0027","author":"National Institute on Drug Abuse"},{"key":"2019061105193904500_CIT0028","author":"Balick"},{"key":"2019061105193904500_CIT0029","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMp1807117","article-title":"Parenteral opioid shortage - treating pain during the opioid-overdose epidemic","volume":"379","author":"Bruera","year":"2018","journal-title":"N Engl J Med"},{"key":"2019061105193904500_CIT0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamainternmed.2015.7431","article-title":"Prevention of low back pain: a systematic review and meta-analysis","volume":"176","author":"Steffens","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2019061105193904500_CIT0031","author":"NIH Medline Plus"},{"key":"2019061105193904500_CIT0032","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"key":"2019061105193904500_CIT0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2019061105193904500_CIT0034"},{"key":"2019061105193904500_CIT0035","author":"Food and Drug Administration"},{"key":"2019061105193904500_CIT0036","article-title":"Florida governor signs major bill to combat opioid epidemic (March 19, 2018)","author":"Reedy"},{"key":"2019061105193904500_CIT0037","article-title":"New Michigan opioid laws may mean longer prescription wait times (May 31, 2018)","author":"Bouffard"},{"key":"2019061105193904500_CIT0038","author":"State of Tennessee"},{"key":"2019061105193904500_CIT0039","unstructured":"National Alliance for Model State Drug Laws. Compilation of prescription monitoring program maps (May 2016).http:\/\/www.namsdl.org\/library\/CAE654BF-BBEA-211E-694C755E16C2DD21\/ (accessed 2019 Feb 13)."},{"key":"2019061105193904500_CIT0040","article-title":"Missouri to start drug program monitoring doctors","year":"2018"},{"key":"2019061105193904500_CIT0041","author":"Pew Charitable Trusts","year":"2018"},{"key":"2019061105193904500_CIT0042","author":"National Association of Boards of Pharmacy"},{"key":"2019061105193904500_CIT0043","author":"Centers for Disease Control and Prevention"},{"key":"2019061105193904500_CIT0044","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpain.2017.11.010","article-title":"The effect of a statewide mandatory prescription drug monitoring program on opioid prescribing by emergency medicine providers across 15 hospitals in a single health system","volume":"19","author":"Suffoletto","year":"2018","journal-title":"J Pain"},{"key":"2019061105193904500_CIT0045","unstructured":"How to get the most out of prescription drug monitoring programs. Presented at the American Pharmacists Association Annual Meeting (March 2018). Nashville, TN. https:\/\/aphameeting.pharmacist.com\/sites\/default\/files\/slides\/Get_the_Most_Out_of_RXDrug_3-18-18_101CD_HO.pdf (accessed 2019 Feb 13)."},{"key":"2019061105193904500_CIT0046","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1377\/hlthaff.2015.1673","article-title":"Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians","volume":"35","author":"Bao","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"2019061105193904500_CIT0047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2015.02.010","article-title":"Abrupt decline in oxycodone-caused mortality after implementation of Florida\u2019s prescription drug monitoring program","volume":"150","author":"Delcher","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"2019061105193904500_CIT0048","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugalcdep.2017.12.002","article-title":"Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings","volume":"184","author":"Pauly","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"2019061105193904500_CIT0049","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.sapharm.2015.07.008","article-title":"Promoting consistent use of prescription drug monitoring programs (PDMP) in outpatient pharmacies: removing administrative barriers and increasing awareness of rx drug abuse","volume":"12","author":"Norwood","year":"2016","journal-title":"Res Social Adm Pharm"},{"key":"2019061105193904500_CIT0050","author":"Centers for Disease Control and Prevention"},{"key":"2019061105193904500_CIT0051","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/hec.3548","article-title":"The effect of state laws designed to prevent nonmedical prescription opioid use on overdose deaths and treatment","volume":"27","author":"Popovici","year":"2018","journal-title":"Health Econ"},{"key":"2019061105193904500_CIT0052","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.2014.18514","article-title":"Mandatory use of prescription drug monitoring programs","volume":"313","author":"Haffajee","year":"2015","journal-title":"JAMA"},{"key":"2019061105193904500_CIT0053","doi-asserted-by":"crossref","DOI":"10.1080\/08897077.2018.1449175","article-title":"Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention","author":"Larson","year":"2018","journal-title":"Subst Abus."},{"key":"2019061105193904500_CIT0054","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2105\/AJPH.2015.302953","article-title":"Opioid overdose deaths and Florida\u2019s crackdown on pill mills","volume":"106","author":"Kennedy-Hendricks","year":"2016","journal-title":"Am J Public Health"},{"key":"2019061105193904500_CIT0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/002204261004000307","article-title":"Prescription drug abuse & diversion: role of the pain clinic","volume":"40","author":"Rigg","year":"2010","journal-title":"J Drug Issues"},{"key":"2019061105193904500_CIT0056","unstructured":"Prescribe to Prevent. Formulations. http:\/\/prescribetoprevent.org\/pharmacists\/formulations\/ (accessed 2019 Feb 13)."},{"key":"2019061105193904500_CIT0057","author":"National Institute on Drug Abuse"},{"key":"2019061105193904500_CIT0058","unstructured":"Prescription Drug Abuse Policy System. Naloxone overdose prevention laws.http:\/\/pdaps.org\/datasets\/laws-regulating-administration-of-naloxone-1501695139 (accessed 2019 Feb 13)."},{"key":"2019061105193904500_CIT0059","first-page":"16","article-title":"Expanding access to naloxone","volume":"43","author":"DeSimone","year":"2018","journal-title":"US Pharm."},{"key":"2019061105193904500_CIT0060","volume-title":"Quality improvement and care coordination: implementing the CDC guideline for prescribing opioids for chronic pain","author":"Centers for Disease Control and Prevention"},{"key":"2019061105193904500_CIT0061","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ajem.2013.06.002","article-title":"Multidisciplinary intervention decreases the use of opioid medication discharge packs from 2 urban EDs","volume":"31","author":"Gugelmann","year":"2013","journal-title":"Am J Emerg Med."},{"key":"2019061105193904500_CIT0062","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jen.2017.09.010","article-title":"A quality improvement project to improve education provided by nurses to ED patients prescribed opioid analgesics at discharge","volume":"44","author":"Waszak","year":"2018","journal-title":"J Emerg Nurs."},{"key":"2019061105193904500_CIT0063","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamainternmed.2017.2468","article-title":"Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial","volume":"177","author":"Liebschutz","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2019061105193904500_CIT0064","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/08897077.2016.1265038","article-title":"Use of risk mitigation practices by family nurse practitioners prescribing opioids for the management of chronic nonmalignant pain","volume":"38","author":"Chaudhary","year":"2017","journal-title":"Subst Abus"},{"key":"2019061105193904500_CIT0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08897077.2016.1275925","article-title":"Opioid overdose prevention training with naloxone, an adjunct to basic life support training for first-year medical students","volume":"38","author":"Berland","year":"2017","journal-title":"Subst Abus"},{"key":"2019061105193904500_CIT0066","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cden.2016.05.003","article-title":"Interprofessional education for the dentist in managing acute and chronic pain","volume":"60","author":"Shaefer","year":"2016","journal-title":"Dent Clin North Am"},{"key":"2019061105193904500_CIT0067","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.adaj.2016.02.017","article-title":"Dental opioid prescribing and multiple opioid prescriptions among dental patients: administrative data from the South Carolina prescription drug monitoring program","volume":"147","author":"McCauley","year":"2016","journal-title":"J Am Dent Assoc"},{"key":"2019061105193904500_CIT0068","doi-asserted-by":"crossref","first-page":"800","DOI":"10.14219\/jada.archive.2011.0268","article-title":"Prevention of prescription opioid abuse: the role of the dentist","volume":"142","author":"Denisco","year":"2011","journal-title":"J Am Dent Assoc"},{"key":"2019061105193904500_CIT0069","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.sapharm.2015.05.001","article-title":"Developing a framework of care for opioid medication misuse in community pharmacy","volume":"12","author":"Cochran","year":"2016","journal-title":"Res Social Adm Pharm"},{"issue":"2S","key":"2019061105193904500_CIT0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.japh.2017.01.006","article-title":"Implementing take-home naloxone in an urban community pharmacy","volume":"57","author":"Akers","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2S","key":"2019061105193904500_CIT0071","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.japh.2017.01.005","article-title":"Indian health service pharmacists engaged in opioid safety initiatives and expanding access to naloxone","volume":"57","author":"Duvivier","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2S","key":"2019061105193904500_CIT0072","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.japh.2017.01.016","article-title":"Opioid exit plan: a pharmacist\u2019s role in managing acute postoperative pain","volume":"57","author":"Genord","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2019061105193904500_CIT0073","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jcpt.12540","article-title":"Impact of pharmacists assisting with prescribing and undertaking medication review on oxycodone prescribing and supply for patients discharged from surgical wards","volume":"42","author":"Tran","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"2019061105193904500_CIT0074","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1331\/JAPhA.2014.13101","article-title":"Pharmacists\u2019 role in addressing opioid abuse, addiction, and diversion","volume":"54","author":"American Pharmacists Association","year":"2014","journal-title":"J Am Pharm Assoc."},{"key":"2019061105193904500_CIT0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.sapharm.2017.12.009","article-title":"Promising roles for pharmacists in addressing the U.S. opioid crisis","author":"Compton","year":"2017","journal-title":"Res Social Adm Pharm."},{"key":"2019061105193904500_CIT0076","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3122\/jabfm.2018.01.170210","article-title":"Impact of pharmacist previsit input to providers on chronic opioid prescribing safety","volume":"31","author":"Cox","year":"2018","journal-title":"J Am Board Fam Med"},{"issue":"2S","key":"2019061105193904500_CIT0077","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.japh.2017.01.010","article-title":"The impact of pharmacy services on opioid prescribing in dental practice","volume":"57","author":"Stewart","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2019061105193904500_CIT0078","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2146\/ajhp160294","article-title":"Implementation of a pharmacist-managed clinic for patients with chronic nonmalignant pain","volume":"74","author":"Norman","year":"2017","journal-title":"Am J Health-Syst Pharm"},{"key":"2019061105193904500_CIT0079","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2146\/ajhp170294","article-title":"Establishment of a pharmacist-led service for patients at high risk for opioid overdose","volume":"75","author":"Tewell","year":"2018","journal-title":"Am J Health-Syst Pharm"},{"key":"2019061105193904500_CIT0080","article-title":"Preparing pharmacy students to manage the opioid crisis","author":"Donohoe","journal-title":"Am J Pharm Educ."},{"key":"2019061105193904500_CIT0081","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2146\/sp140002","article-title":"ASHP statement on the pharmacist\u2019s role in substance abuse prevention, education, and assistance","volume":"71","year":"2014","journal-title":"Am J Health-Syst Pharm."},{"key":"2019061105193904500_CIT0082","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ptdy.2016.08.004","article-title":"APhA emphasizes pharmacists\u2019 role in curbing opioid abuse, improving treatment","volume":"22","author":"Meninghan","year":"2016","journal-title":"Pharmacy Today."},{"key":"2019061105193904500_CIT0083","author":"American College of Clinical Pharmacy","year":"2018"},{"key":"2019061105193904500_CIT0084","author":"Drug Enforcement Administration"},{"key":"2019061105193904500_CIT0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2146\/news180013","article-title":"Medical treatment is key in battling opioid crisis","volume":"75","author":"Traynor","year":"2018","journal-title":"Am J Health-Syst Pharm"},{"key":"2019061105193904500_CIT0086","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2013tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"2019061105193904500_CIT0087","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harv Rev Psychiatry"},{"key":"2019061105193904500_CIT0088","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009","volume":"103","author":"Schwartz","year":"2013","journal-title":"Am J Public Health"},{"key":"2019061105193904500_CIT0089","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2016.05.002","article-title":"Impact of medication-assisted treatment for opioid addiction on Medicaid expenditures and health services utilization rates in Vermont","volume":"67","author":"Mohlman","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"2019061105193904500_CIT0090","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth Analg"},{"key":"2019061105193904500_CIT0091","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2146\/ajhp161021","article-title":"Minimizing opioid use after acute major trauma","volume":"75","author":"Oyler","year":"2018","journal-title":"Am J Health-Syst Pharm"},{"key":"2019061105193904500_CIT0092","author":"American Pharmacists Association"},{"key":"2019061105193904500_CIT0093","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs","volume":"8","author":"Clark","year":"2014","journal-title":"J Addict Med"},{"key":"2019061105193904500_CIT0094","article-title":"Barriers and facilitators to dispensing of intranasal naloxone by pharmacists","author":"Bakhireva","year":"2017","journal-title":"Subst Abus."},{"key":"2019061105193904500_CIT0095","unstructured":"Abrams A . The surgeon general says more people should carry naloxone, the opioid antidote. Here\u2019s where to get it and how much it costs (April 5, 2018). http:\/\/time.com\/5229870\/naloxone-surgeon-general-cost-where-buy\/ (accessed 2019 Feb 13)."},{"key":"2019061105193904500_CIT0096","unstructured":"University of Texas at Austin College of Pharmacy. New student orientation.http:\/\/sites.utexas.edu\/pharmacy-nso\/ (accessed 2019 Feb 13)."},{"key":"2019061105193904500_CIT0097","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cptl.2017.09.007","article-title":"A naloxone and harm reduction educational program across four years of a Doctor of Pharmacy program","volume":"10","author":"Maguire","year":"2018","journal-title":"Curr Pharm Teach Learn"},{"key":"2019061105193904500_CIT0098","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jpain.2013.04.011","article-title":"Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010","volume":"14","author":"Severtson","year":"2013","journal-title":"J Pain"},{"key":"2019061105193904500_CIT0099","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/03007995.2017.1419171","article-title":"Abuse-deterrent opioids: an update on current approaches and considerations","volume":"34","author":"Pergolizzi","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"2019061105193904500_CIT0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.drugalcdep.2016.06.009","article-title":"Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (oxycontin)","volume":"165","author":"Chilcoat","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"2019061105193904500_CIT0101","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cpt.390","article-title":"The effect of an abuse-deterrent opioid formulation (oxycontin) on opioid abuse-related outcomes in the postmarketing setting","volume":"100","author":"Coplan","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"2019061105193904500_CIT0102","article-title":"Mandating coverage of abuse-deterrent opioids would be a costly distraction from more effective solutions (May 26, 2017)","author":"Manolis"},{"key":"2019061105193904500_CIT0103","author":"Institute for Clinical and Economic Review"},{"key":"2019061105193904500_CIT0104","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.2196\/jmir.3397","article-title":"Monitoring of internet forums to evaluate reactions to the introduction of reformulated oxycontin to deter abuse","volume":"16","author":"McNaughton","year":"2014","journal-title":"J Med Internet Res"},{"key":"2019061105193904500_CIT0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/JMDH.S166915","article-title":"An overview of abuse-deterrent opioids and recommendations for practical patient care","volume":"11","author":"Adler","year":"2018","journal-title":"J Multidiscip Healthc"},{"key":"2019061105193904500_CIT0106","first-page":"E1003","article-title":"Current impact and application of abuse-deterrent opioid formulations in clinical practice","volume":"20","author":"Lee","year":"2017","journal-title":"Pain Physician"},{"key":"2019061105193904500_CIT0107","article-title":"Living in an opioid world: the pressing need for improved substance use disorder education (December 11, 2018)","author":"Hamilton"},{"key":"2019061105193904500_CIT0108","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/PHH.0000000000000807","article-title":"The North American opioid experience and the role of community pharmacy","volume":"24","author":"Rosenberg-Yunger","year":"2018","journal-title":"J Public Health Manag Pract"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/76\/7\/424\/28791253\/zxy089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T20:47:11Z","timestamp":1663102031000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/76\/7\/424\/5382447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":108,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,3,19]]},"published-print":{"date-parts":[[2019,3,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxy089","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,1]]},"published":{"date-parts":[[2019,3,19]]}}}